These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 28859138)
1. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry. Monasta L; Pierobon C; Princivalle A; Martelossi S; Marcuzzi A; Pasini F; Perbellini L PLoS One; 2017; 12(8):e0184118. PubMed ID: 28859138 [TBL] [Abstract][Full Text] [Related]
2. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study. Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410 [TBL] [Abstract][Full Text] [Related]
3. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study. Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596 [TBL] [Abstract][Full Text] [Related]
5. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease. van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048 [TBL] [Abstract][Full Text] [Related]
6. Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients. Belnour S; Slater R; Tharmaratnam K; Karl-Heinz Auth M; Muhammed R; Spray C; Wang D; Zeeshan Ijaz U; Probert C; Allen S United European Gastroenterol J; 2024 Jul; 12(6):780-792. PubMed ID: 38922802 [TBL] [Abstract][Full Text] [Related]
7. Diagnosing Inflammatory bowel disease using noninvasive applications of volatile organic compounds: a systematic review. Bannaga AS; Farrugia A; Arasaradnam RP Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1113-1122. PubMed ID: 31657950 [No Abstract] [Full Text] [Related]
8. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis. Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264 [TBL] [Abstract][Full Text] [Related]
9. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study. Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848 [TBL] [Abstract][Full Text] [Related]
10. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis. Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741 [TBL] [Abstract][Full Text] [Related]
11. Faecal Volatile Organic Compound Analysis in De Novo Paediatric Inflammatory Bowel Disease by Gas Chromatography-Ion Mobility Spectrometry: A Case-Control Study. Vermeer E; Jagt JZ; Stewart TK; Covington JA; Struys EA; de Jonge R; de Boer NKH; de Meij TGJ Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732837 [TBL] [Abstract][Full Text] [Related]
12. Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach. Bodelier AG; Smolinska A; Baranska A; Dallinga JW; Mujagic Z; Vanhees K; van den Heuvel T; Masclee AA; Jonkers D; Pierik MJ; van Schooten FJ Inflamm Bowel Dis; 2015 Aug; 21(8):1776-85. PubMed ID: 26199990 [TBL] [Abstract][Full Text] [Related]
13. Gas Chromatography-Sensor System Aids Diagnosis of Inflammatory Bowel Disease, and Separates Crohn's from Ulcerative Colitis, in Children. Slater R; Tharmaratnam K; Belnour S; Auth MK; Muhammed R; Spray C; Wang D; de Lacy Costello B; García-Fiñana M; Allen S; Probert C Sensors (Basel); 2024 Aug; 24(15):. PubMed ID: 39124126 [TBL] [Abstract][Full Text] [Related]
14. The Diagnostic Utility of Volatile Organic Compounds in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Krishnamoorthy A; Chandrapalan S; Ahmed M; Arasaradnam RP J Crohns Colitis; 2024 Feb; 18(2):320-330. PubMed ID: 37540200 [TBL] [Abstract][Full Text] [Related]
15. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry. Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824 [TBL] [Abstract][Full Text] [Related]
16. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [TBL] [Abstract][Full Text] [Related]
17. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study. Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410 [TBL] [Abstract][Full Text] [Related]
18. Fecal proteolytic profiling of pediatric inflammatory bowel disease: A pilot study. Haak W; Jagt JZ; de Meij TGJ; Bikker FJ; Brand HS; de Boer NKH; Kaman WE FASEB J; 2024 May; 38(9):e23627. PubMed ID: 38690708 [TBL] [Abstract][Full Text] [Related]
19. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective. Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476 [TBL] [Abstract][Full Text] [Related]